EMA Withdrawn: Capecitabine SUN (capecitabine) — Sun Pharmaceutical Industries Europe B.V.

View source ↗

Summary

Capecitabine SUN (capecitabine) has been withdrawn from the European market by Sun Pharmaceutical Industries Europe B.V.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms
• Colonic Neoplasms
• Colorectal Neoplasms
• Stomach Neoplasms

Drugs mentioned

• Capecitabine SUN (capecitabine)

Snippet

Status: Withdrawn. Therapeutic area: Stomach Neoplasms;Breast Neoplasms;Colonic Neoplasms;Colorectal Neoplasms. MAH: Sun Pharmaceutical Industries Europe B.V.. Decision date: 21/06/2016